Patient education on cardiovascular aspects of rheumatoid disease: An unmet need

Rheumatology

Volumn 46, Issue 10, 2007, Pages 1513-1516

  John, Holly ^a   Hale, E D ^a   Treharne, G J ^a,b   Kitas, G D ^a,b,c  

^a DUDLEY GROUP OF HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE; LEFLUNOMIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; COMORBIDITY; DAILY LIFE ACTIVITY; DECISION MAKING; DYSLIPIDEMIA; EDITORIAL; EDUCATION PROGRAM; EXERCISE; HEALTH BEHAVIOR; HEALTH CARE NEED; HEALTH PRACTITIONER; HEALTH STATUS; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; OBESITY; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SATISFACTION; PILOT STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SMOKING; SURVIVAL RATE;

ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; HUMANS; PATIENT EDUCATION AS TOPIC;

EID: 34848836109     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem176     Document Type: Editorial

References (63)

1. Symmons D, Turner G, Webb R et al. The prevalence of rheumatoid arthritis in the United Kingdom: New estimates for a new century. Rheumatology 2002;41:793-800.
2. Symmons DP. Looking back: Rheumatoid arthritis-aetiology, occurrence and mortality. Rheumatology 2005;44(Suppl 4):iV14-7.
3. Erb N, Pace AV, Douglas KM, Banks MJ, Kitas GD. Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 2004;33:293-9.
4. Goodson N. Coronary artery disease and rheumatoid arthritis. Curr Opin Rheumatol 2002;14:115-20.
5. Kroot EJ, van Gestel AM, Swinkels HL, Albers MM, van de Putte LB, Van Riel PL. Chronic comorbidity in patients with early rheumatoid arthritis: A descriptive study. J Rheumatol 2001;28:1511-7.
6. Bacon PA, Kitas GD. The significance of vascular inflammation in rheumatoid arthritis. Ann Rheum Dis 1994;53:621-3.
7. Kitas GD, Erb N. Tackling ischaemic heart disease in rheumatoid arthritis. Rheumatology 2003;42:607-13.
8. Hall FC, Dalbeth N. Disease modification and cardiovascular risk reduction: Two sides of the same coin? Rheumatology 2005;44:1473-82.
9. Banks M, Kitas G. Patients' physical disability may influence doctors' perceptions of suitability for risk assessment of CHD. Br Med J 1999;319:1266-7.
10. Justice E, Carruthers DM. Cardiovascular risk and COX-2 inhibition in rheumatological practice. J Hum Hypertens 2005;19:1-5.
11. Metsios GS, Stavropoulos-Kalinoglou A, Veldhuijzen van Zanten J et al. Rheumatoid arthritis cardiovascular disease and physical exercise: A systematic review. Rheum 2007 (in press).
12. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-26.
13. Klocke R, Cockcroft JR, Taylor GJ, Hall IR, Blake DR. Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Ann Rheum Dis 2003;62:414-8.
14. Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: A prospective study. Lancet 2002;359:1173-7.
15. Mitchell DM, Spitz PW, Young DY, Bloch DA, McShane DJ, Fries JF. Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum 1986;29:706-14.
16. Lehtinen K, Isomaki H. Intramuscular gold therapy is associated with long survival in patients with rheumatoid arthritis. J Rheumatol 1991;18:524-9.
17. Krause D, Schleusser B, Herborn G, Rau R. Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum 2000;43:14-21.
18. Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how 'high-grade' systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003;108:2957-63.
19. Stevens RJ, Douglas KM, Saratzis AN, Kitas GD. Inflammation and atherosclerosis in rheumatoid arthritis. Expert Rev Mol Med 2005;7:1-24.
20. British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, The Stroke Association JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005;91(Suppl 5):v1-v4.
21. Thomson R, Edwards A, Grey J. Risk communication in the clinical consultation. Clin Med 2005;5:465-9.
22. Appel LJ, Champagne CM, Harsha DW et al. Effects of comprehensive lifestyle modification on blood pressure control: Main results of the PREMIER clinical trial. JAMA 2003;289:2083-93.
23. Im-Roijer C, Stagmo M, Uden G, Erhardt L. Better knowledge improves adherence to lifestyle changes and medication in patients with coronary heart disease. Eur J Cardiovasc Nurs 2004;3:321-30.
24. Aldana SG, Whitmer WR, Greenlaw R et al. Cardiovascular risk reductions associated with aggressive lifestyle modification and cardiac rehabilitation. Heart Lung 2003;32:374-82.
25. Clifford RM, Davis WA, Batty KT, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: The Fremantle Diabetes Study. Diabetes Care 2005;28:771-6.
26. Rachmani R, Slavacheski I, Berla M, Frommer-Shapira R, Ravid M. Treatment of high-risk patients with diabetes: Motivation and teaching intervention: A randomized, prospective 8-year follow-up study. J Am Soc Nephrol 2005;16(Suppl 1):S22-6.
27. Kennedy T, McCabe C, Struthers G et al. BSR guidelines on standards of care for persons with rheumatoid arthritis. Rheumatology 2005;44:553-6.
28. Arthritis and Musculoskeletal Alliance. Standards of care for inflammatory arthritis. 2004. London. Available at: http://www.arma.uk.net/pdfs/ia06.pdf
29. Symmons D, Bruce I. Hands On management of cardiovascular risk in RA and SLE. Hands on: Arc Reports on the rheumatic diseases. Series 5, Number 8, 2006.
30. National Rheumatoid Arthritis Society. National Rheumatoid Arthritis Society Survey. 2006. Available at: http://www.rheumatoid.org.uk/ index.php?page_id=30
31. Treharne GJ, Lyons AC, Hale ED, Douglas KM, Kitas GD. 'Compliance' is futile but is 'concordance' between rheumatology patients and health professionals attainable? Rheumatology 2006;45:1-5.
32. Wagner J, Lacey K, Chyun D, Abbott G. Development of a questionnaire to measure heart disease risk knowledge in people with diabetes: The heart disease fact questionnaire. Patient Educ Couns 2005;58:82-7.
33. Treharne GJ, Hale ED, Lyons AC et al. Cardiovascular disease and psychological morbidity among rheumatoid arthritis patients. Rheumatology 2005;44:241-6.
34. Lorig K. Common sense patient education. Victoria, Australia: Fraser Publications, 1992.
35. Chachkes E, Christ G. Cross cultural issues in patient education. Patient Educ Couns 1996;27:13-21.
36. Rogers J, Matsumura M. Mother to be: A guide to pregnancy and birth for women with disabilities. New York: Demos, 1991.
37. Dunnill MG, Pounder RE. Medical outpatients: Changes that can benefit patients. Clin Med 2004;4:45-9.
38. Barlow JH, Wright CC. Knowledge in patients with rheumatoid arthritis: A longer term follow-up of a randomized controlled study of patient education leaflets. Br J Rheumatol 1998;37:373-6.
39. Knight KM, Dornan T, Bundy C. The diabetes educator: Trying hard, but must concentrate more on behaviour. Diabet Med 2006;23:485-501.
40. Daltroy LH, Liang MH. Advances in patient education in rheumatic disease. Ann Rheum Dis 1991;30:415-7.
41. Tucker M, Kirwan JR. Does patient education in rheumatoid arthritis have therapeutic potential? Ann Rheum Dis 1991;50:422-8.
42. Bandura A. Self-efficacy: Toward a unifying theory of behavioural change. Psychol Rev 1977;84:191-215.
43. Ogden J. Health beliefs. Health psychology: A textbook Open University Press, Berkshire, 2004;13-46.
44. Davis P, Busch AJ, Lowe JC, Taniguchi J, Djkowich B. Evaluation of a rheumatoid arthritis patient education program: Impact on knowledge and self-efficacy. Patient Educ Couns 1994;24:55-61.
45. Lindroth Y, Brattstrom M, Bellman I et al. A problem-based education program for patients with rheumatoid arthritis: Evaluation after three and twelve months. Arthritis Care Res 1997;10:325-32.
46. Riemsma RP, Taal E, Kirwan JR, Rasker JJ. Systematic review of rheumatoid arthritis patient education. Arthritis Rheum 2004;51:1045-59.
47. Hill J. A practical guide to patient education and information giving. Ballieres Clin Rheum 1997;11:109-27.
48. Osborne RH, Spinks JM, Wicks IP. Patient education and self-management programs in arthritis. Med J Aust 2007;180:S23-6.
49. Taal E, Riemsma RP, Brus HLM, Seydel ER, Rasker JJ, Weigman O. Group education for patients with rheumatoid arthritis. Patient Educ Couns 1993;20:177-87.
50. Arthritis Care. Arthritis care self management programmes. Arthritis Care. 2007. Available at: http://www.arthritiscare.org.uk/ PublicationsandResources/Self-managementprogrammes?region=uk
51. Barlow JH, Turner AP, Wright CC. A randomized controlled study of the Arthritis Self- Management Programme in the UK. Health Educ Res 2000;15:665-80.
52. Lorig K, Ritter P, Stewart AL et al. Chronic disease self-management program: 2-year health status and health care utilization outcomes. Med Care 2001;39:1217-23.
53. Adab P, Rankin EC, Witney AG et al. Use of a corporate needs assessment to define the information requirements of an arthritis resource centre in Birmingham: Comparison of patients' and professionals' views. Rheumatology 2004;43:1513-8.
54. Kirwan JR. Patient education in rheumatoid arthritis. Curr Opin Rheumatol 1990;2:336-9.
55. Riemsma RP, Taal E, Brus HLM, Rasker JJ, Weigman O. Coordinated individual education with an arthritis passport for patients with rheumatoid arthritis. Arthritis Care Res 1997;10:238-49.
56. Croyle RT, Loftus EF, Barger SD, Sun YC, Hart M, Gettig J. How well do people recall risk factor test results? Accuracy and bias among cholesterol screening participants. Health Psychol 2006;25:425-32.
57. Barlow JH, Cullen LA, Rowe IF. Educational preferences, psychological well-being and self-efficacy among people with rheumatoid arthritis. Patient Educ Couns 2002;46:11-19.
58. Riemsma RP, Taal E, Rasker JJ. Group education for patients with rheumatoid arthritis and their partners. Arthritis Rheum 2003;49:556-66.
59. Neville C, Fortin PR, Fitzcharles MA et al. The needs of patients with arthritis: The patient's perspective. Arthritis Care Res 2007;12:85-95.
60. Gordon MM, Thomson EA, Madhok R, Capell HA. Can intervention modify adverse lifestyle variables in a rheumatoid population? Results of a pilot study. Ann Rheum Dis 2002;61:66-9.
61. Treharne GJ, Douglas KMJ, Iwaszko J et al. Polypharmacy among people with rheumatoid arthritis: The relationship the role of age, disease duration and comorbidity. Musculoskeletal Care, 2007 (in press).
62. Hill J. Rheumatology nurse specialists - do we need them? Rheumatology 2007;46:379-81.
63. Hale ED, Treharne GJ, Peacock SM, Bonas S, Kitas GD. Defining the role of health psychologists in rheumatology. Rheumatology 2007;46(Suppl 1):i148.